secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001757898-24-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STERIS Q1 FY2025 revenue $1.3B (+8%), adjusted EPS $2.03; guidance reiterated
-----------------------------------------------------------------------------

- Total revenue from continuing ops $1.3B, up 8% YoY; constant currency organic revenue up 6%.
- As-reported EPS $1.41 (from $1.31), adjusted EPS $2.03 (from $1.84).
- Healthcare revenue +10% to $901.2M; AST +7% to $249.8M; Life Sciences -2% to $128.5M due to CECS divestiture.
- Segment operating income all up: Healthcare $216.9M, AST $117.7M, Life Sciences $52.6M.
- FY2025 guidance reaffirmed: rev growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/0001757898-24-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000175789824000014/ste-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001757898-24-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer